Amylyx (AMLX) Q3 2026 Earnings Call Transcript

Phase 3 LUCIDITY results keep avexitide on track toward a 2027 launch.

fool.com ·2h ago

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

More in Finance & Markets

Management flagged rising delinquencies ahead as recent book years season.

2h ago ·fool.com

ClearanceJobs booked its best new business quarter ever as Dice renewals stayed under strain.

2h ago ·fool.com

Record revenue and margins as AI and semiconductor demand surge across markets.

2h ago ·fool.com

Novo Nordisk milestone payment shapes quarter as HCM readout nears.

2h ago ·fool.com

A CFO exit and cost cuts dominate, but B2B pipeline momentum stood out.

2h ago ·fool.com

Payments-based revenue rose 18% as Shift4 expanded across key verticals.

2h ago ·fool.com